In this articleSQZMMSFTWORKPhil Libin, CEO of All Turtles and MmhmmCNBCIn December, internet entrepreneur Phil Libin loaded up his car and, along with his girlfriend, drove almost 2,000 miles from his home in San Francisco to…
Here are key ways the coronavirus crisis differs…
For the second time in 12 years, the U.S. economy and financial markets are facing an unexpected crisis of uncertain proportions.While the 2008 financial crisis and the current coronavirus pandemic are very different in character,…
Cramer says the stock market is too optimistic…
CNBC's Jim Cramer said Wednesday that he thought some stocks were rallying too far too quickly given the high level of unemployment in the United States as the economy tries to pull out of the…
Issue of RBI 7.75% bonds closes on May…
The Reserve Bank of India (RBI) has announced that 7.75 per cent Savings (Taxable) bonds, 2018 will not be available for investment from Friday i.e. May 29, 2020. In its press release, the central bank…
Zoom Video names Indian-origin Velchamy Sankarlingam as president…
Bengaluru: Zoom Video Communications, Inc. appointed Indian-origin Velchamy Sankarlingam as the President of Engineering and Product. Sankarlingam comes to Zoom after more than nine years at VMware, where he was most recently Senior Vice President,…
Facing liquidity crunch due to Covid, promoters and…
Mumbai: Tight liquidity could see scenarios of fund diversion, round tripping and evergreening of loans in a desperate bid by some companies to beat the economic headwinds from the Covid-19 crisis, a PwC report said.…
Did you retire between Feb and April? You…
The Ministry of Finance has relaxed the time limit of investing in Senior Citizen Savings Scheme (SCSS) for individuals who retired between February and April 2020. This is good news because as per the scheme…
Hold Thyrocare Technologies, target price Rs 541: ICICI…
ICICI Securities has given a hold rating to Thyrocare Technologies with a discounted cash flow-based target price of Rs 541, implying 23 times FY22E earnings and 14.2 times FY22E EBITDA. Thyrocare Technologies’ reported a weak…